C. R. Bard
Clinical trials sponsored by C. R. Bard, explained in plain language.
Medical device company, acquired by BD, known for vascular and urology products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a less invasive catheter replace the tube in intensive care? Results expected Oct 2026 (estimated)
- New balloon could help dialysis patients avoid repeat procedures Results expected Apr 2027 (estimated)
- New device aims to simplify dialysis access for kidney patients Results expected Jun 2027 (estimated)
-
New radiofrequency device aims to seal off problem veins
Disease control OngoingThis study tests a device that uses radiofrequency energy to close off damaged veins in the legs, helping blood flow better and easing symptoms like pain and swelling. About 200 adults with chronic venous insufficiency are taking part. The main goals are to see if the treated vei…
Sponsor: C. R. Bard • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New balloon could help dialysis patients avoid repeat procedures
Disease control OngoingThis study looks at a special balloon coated with medicine that is used to open up blocked dialysis fistulas in the arm. The goal is to see if it keeps the fistula working longer and safely. About 213 people took part in this global study.
Sponsor: C. R. Bard • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could a simple mesh stop painful hernias after surgery?
Prevention OngoingThis study tests whether placing a special mesh (Phasix) during abdominal closure can prevent incisional hernias in people at high risk. About 477 adults having open abdominal surgery will be randomly assigned to get the mesh or standard stitches. The main goal is to see if the m…
Sponsor: C. R. Bard • Aim: Prevention
Last updated Aug 22, 2026 00:00 UTC
-
Unapproved device tested in early trial
Knowledge-focused OngoingThis trial is testing a medical device that has not been approved or cleared by the U.S. FDA. The study is small and early-stage, focused on understanding how the device works and whether it is safe. No results are available yet, and the device is not ready for widespread use.
Sponsor: C. R. Bard • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC